Investors Trust’s iShares Biotechnology ETF IBB Stock Holding History

Investors Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-5,646	Closed	-$515K	–	51
2014 Q3	$515K	Sell	5,646 -4,797	-46%	-$421K	0.95%	42
2014 Q2	$895K	Sell	10,443 -405	-4%	-$31.9K	0.7%	47
2014 Q1	$855K	Hold	10,848	–	–	0.72%	45
2013 Q4	$891K	Buy	+10,848	New	+$770K	0.69%	48

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Investors Trust's IBB Position: Q4 2014 in Review

Investors Trust sold out of iShares Biotechnology ETF (IBB) in Q4 2014, closing a stake of 5,646 shares — an estimated $515K sold.

Investors Trust first reported a position in IBB in Q4 2013 and held it in 4 quarters. The position peaked at $895K in Q2 2014. 370 funds tracked by Wall St. Rank hold IBB as of Q4 2014.

Investors Trust reported no remaining iShares Biotechnology ETF position as of Q4 2014 after selling out during the quarter.
Investors Trust sold 5,646 iShares Biotechnology ETF shares in Q4 2014, an estimated $515K.
Investors Trust first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 4 quarters.
Investors Trust's iShares Biotechnology ETF position peaked at $895K in Q2 2014.
370 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2014.

Based on Investors Trust's 13F filing for Q4 2014, filed 17 Feb 2015.